OBIO$5.713.38%-0.20
Orchestra Biomed Holdings Inc (OBIO)
Date: 2026-11-02 16:00O: 6.00H: 6.02L: 5.66C: 5.72Vol: 235.2k
Orchestra Biomed Holdings Inc stock is traded at $5.71, with a volume of 244,943. It is down -3.38% in the last 24 hours and down -4.03% over the past month. Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
Previous Close:
$5.91
Open:
$6.00
24h Volume:
244,943
Relative Volume:
0.63
Market Cap:
$343.20M
Revenue:
$32.72M
Net Income/Loss:
-$54.64M
P/E Ratio:
-
EPS:
-$1.13
Net Cash Flow:
-$55.08M
1W Performance:
+2.88%
1M Performance:
-4.03%
6M Performance:
+43.83%
1Y Performance:
+46.41%
1-Day Range:
$5.66$6.02
1-Week Range:
$5.52$6.16
52-Week Range:
$3.46$6.50
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Name
Orchestra Biomed Holdings IncSector
HealthcareIndustry
BiotechnologyPhone
646-343-9298Address
150 UNION SQUARE DRIVE, NEW HOPE, USACompare OBIO vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
OBIO Orchestra Biomed Holdings Inc | $343.20M | $31.98M | -$59.03M | -$55.08M | -$1.13 |
 VRTX Vertex Pharmaceuticals Inc | $138.47B | $12.59B | $4.41B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $99.83B | $16.90B | $4.82B | $3.79B | $41.04 |
 MRNA Moderna Inc | $87.64B | $2.23B | -$3.15B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $55.13B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $41.12B | $6.13B | $655.71M | $1.10B | $4.48 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
Orchestra Biomed Holdings Inc Stock (OBIO) Financials Data
Orchestra Biomed Holdings Inc Stock (OBIO) Insider Trading
- Sherman DarrenOct 01 '26Officer
- Transaction
- Proposed Sale
- Cost
- $6.27
- #Shares
- 15,000
- Value ($)
- 94,050
- #Shares Total
- 0
- Hochman David PSep 03 '26See Remarks
- Transaction
- Buy
- Cost
- $4.79
- #Shares
- 10,000
- Value ($)
- 47,900
- #Shares Total
- 1,070,746
- Sherman DarrenSep 01 '26Officer
- Transaction
- Proposed Sale
- Cost
- $5.02
- #Shares
- 15,000
- Value ($)
- 75,300
- #Shares Total
- 0
- Sherman DarrenSep 01 '26See Remarks
- Transaction
- Sale
- Cost
- $4.94
- #Shares
- 15,000
- Value ($)
- 74,100
- #Shares Total
- 1,134,402
- Sherman DarrenAug 26 '26See Remarks
- Transaction
- Buy
- Cost
- $5.33
- #Shares
- 2,000
- Value ($)
- 10,660
- #Shares Total
- 2,000
- Sherman DarrenAug 03 '26Officer
- Transaction
- Proposed Sale
- Cost
- $4.09
- #Shares
- 15,000
- Value ($)
- 61,292
- #Shares Total
- 0
- Sherman DarrenAug 03 '26See Remarks
- Transaction
- Sale
- Cost
- $4.09
- #Shares
- 15,000
- Value ($)
- 61,350
- #Shares Total
- 1,154,327
- Sherman DarrenJul 01 '26Officer
- Transaction
- Proposed Sale
- Cost
- $4.32
- #Shares
- 15,000
- Value ($)
- 64,800
- #Shares Total
- 0
- Sherman DarrenJun 01 '26Officer
- Transaction
- Proposed Sale
- Cost
- $3.87
- #Shares
- 15,000
- Value ($)
- 58,050
- #Shares Total
- 0
- Sherman DarrenJun 01 '26See Remarks
- Transaction
- Sale
- Cost
- $3.87
- #Shares
- 15,000
- Value ($)
- 58,050
- #Shares Total
- 1,184,327
